Advanced Parenteral Drug Delivery Devices Market Research Key Players, Industry Overview, Supply Chain and Analysis 2018 – 2025
Parenteral administration route is coined as the most common and efficient for drug delivery of active drug substances with poor bio-availability and drugs with a narrow therapeutic index. For parenteral drug delivery to be an efficient and effective treatment it is often appropriate to uphold systemic drug levels within the therapeutically effective concentration range in cases of long treatment
Parenteral administration route is coined as the most common and efficient for drug delivery of active drug substances with poor bio-availability and drugs with a narrow therapeutic index. For parenteral drug delivery to be an efficient and effective treatment it is often appropriate to uphold systemic drug levels within the therapeutically effective concentration range in cases of long treatment
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Global <strong>Advanced</strong> <strong>Parenteral</strong> <strong>Drug</strong> <strong>Delivery</strong> <strong>Devices</strong> market competition by top manufacturers, with production,<br />
price, revenue (value) <strong>and</strong> market share for each manufacturer; the top players including<br />
• Abbott Laboratories<br />
• Amgen<br />
• Pfizer<br />
• Hoffmann-La Roche<br />
• AstraZeneca<br />
• Baxter<br />
See More Reports of This Category by Million Insights @<br />
https://www.millioninsights.com/industry/medical-devices<br />
On the basis of product, this report displays the production, revenue, price, market share <strong>and</strong> growth rate of each<br />
type, primarily split into<br />
• Prefillable Syringes<br />
• Injectors Cartridges<br />
• Hypodermic Syringes<br />
• IV Catheters<br />
• Other <strong>Parenteral</strong> <strong>Delivery</strong> <strong>Devices</strong><br />
On the basis of the end users/applications, this report focuses on the status <strong>and</strong> outlook for major applications/end<br />
users, consumption (sales), market share <strong>and</strong> growth rate for each application, including<br />
• Central Nervous System Agents<br />
• Respiratory Agents<br />
• Hrmones & Related Agents<br />
• Gastrointestinal Agents
Change language